Apomorphine


Thông tin thuốc gốc
Chỉ định và Liều dùng
Subcutaneous
Refractory motor fluctuations in Parkinson's disease
Adult: Initially, 1 mg at the 1st sign of an "off" episode, then a further 2 mg if inadequate or no response after 30 min. Subsequent increments can be made at intervals of at least 40 min until satisfactory response obtained. Usual dose range: 3-30 mg daily in divided doses. Patient requiring >10 inj/day: Initially, 1 mg/hr via continuous SC infusion increased not more often than 4 hrly in max increments of 500 mcg/hr, to usual rate of 1-4 mg/hr (15-60 mcg/kg/hr). Should only be given during waking hr and change infusion site 12 hrly. Intermittent bolus inj may be required to supplement the infusion. Max: 100 mg/day and 10 mg/dose.
Renal Impairment
Mild to moderate: Reduce initial dose.
Chống chỉ định
Patient w/ resp or CNS depression, neuropsychiatric problems, or dementia. Patient who has "on" response to levodopa marred by severe dyskinesia or dystonia.
Thận trọng
Patient prone to nausea and vomiting or when vomiting is likely to pose a risk. Patient w/ pulmonary, CV, or endocrine disease, history of orthostatic hypotension. Renal and hepatic impairment. Elderly or debilitated patients. Pregnancy and lactation.
Phản ứng phụ
Yawning, dyskinesias, nausea and/or vomiting, somnolence, transient sedation, dizziness, oedema, chest pain, orthostatic hypotension, postural instability and falls, increased salivation and perspiration, neuropsychiatric disturbances. Signs of CNS stimulation (e.g. euphoria, lightheadedness, restlessness, tremor, tachycardia and tachypnoea). Induration, nodule formation, and panniculitis, sometimes leading to ulceration, often develops at the site of inj. Rarely, eosinophilia.
Parenteral/SC: C
Thông tin tư vấn bệnh nhân
This drug may cause somnolence and/or an episode of sudden sleep onset, if affected do not drive or operate machinery.
MonitoringParameters
Periodic monitoring of hepatic, renal, haematopoietic, and CV function.
Quá liều
Symptoms: Persistent vomiting, resp depression, bradycardia, hypotension, and coma; death may occur. Management: Excessive emesis may be treated w/ domperidone. An opioid antagonist (e.g. naloxone) has been given to treat CNS and resp depression. Appropriate measures must be taken (e.g. raising the foot of the bed) in case of hypotension. May use atropine in bradycardia.
Tương tác
May potentiate hypotensive effects of antihypertensives or organic nitrates. Antipsychotics and other drugs that act as CNS dopamine inhibitors may antagonise therapeutic effects of apomorphine. Additive effect on QT interval prolongation w/ drugs known to prolong the QT interval (e.g. TCAs, antipsychotic agents). May enhance effect w/ memantine and entacapone.
Food Interaction
Enhanced hypotensive effects w/ alcohol.
Tác dụng
Description: Apomorphine is a nonergot-derivative potent dopamine D1- and D2-receptor agonist. It stimulates postsynaptic dopamine D2 receptors w/in the caudate-putamen in the brain.
Onset: Rapid.
Pharmacokinetics:
Absorption: Well absorbed.
Distribution: Volume of distribution: 218 L. Plasma protein binding: Approx 90% (mainly albumin).
Metabolism: Undergoes conjugation w/ glucuronic acid or sulfate to its major metabolite apomorphine sulfate and demethylation to form norapomorphine.
Excretion: Via urine (93%) as metabolites and faeces (16%). Terminal elimination half-life: 40 min.
Đặc tính

Chemical Structure Image
Apomorphine

Source: National Center for Biotechnology Information. PubChem Database. Apomorphine, CID=6005, https://pubchem.ncbi.nlm.nih.gov/compound/Apomorphine (accessed on Jan. 21, 2020)

Bảo quản
Store below 25°C. Protect from light.
Phân loại MIMS
References
Anon. Apomorphine. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 20/05/2014.

Buckingham R (ed). Apomorphine Hydrochloride. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 20/05/2014.

Joint Formulary Committee. Apomorphine Hydrochloride. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 20/05/2014.

McEvoy GK, Snow EK, Miller J et al (eds). Apomorphine Hydrochloride. AHFS Drug Information (AHFS DI) [online]. American Society of Health-System Pharmacists (ASHP). https://www.medicinescomplete.com. Accessed 20/05/2014.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Apomorphine từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2021 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in